Penbrook Management LLC Codex Dna, Inc. Transaction History

Penbrook Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	SELL	N/A	-9,245 Reduced 2.54%	354,325 $655,000
Q3 2023 Oct 10, 2023	SELL	N/A	-200 Reduced 0.05%	363,570 $672,000
Q2 2023 Jul 17, 2023	BUY	N/A	21,300 Added 6.22%	363,770 $672,000
Q1 2023 Apr 20, 2023	BUY	$1.3 - $2.15 $95,706 - $158,283	73,620 Added 27.38%	342,470 $633,000
Q3 2022 Oct 31, 2022	BUY	$1.7 - $2.36 $140,352 - $194,841	82,560 Added 44.32%	268,850 $446,000
Q2 2022 Jul 29, 2022	BUY	$1.8 - $6.45 $75,823 - $271,699	42,124 Added 29.22%	186,290 $335,000
Q1 2022 Apr 26, 2022	BUY	$4.12 - $10.36 $593,963 - $1.49 Million	144,166 New	144,166 $774,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Penbrook Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penbrook Management LLC with notifications on news.